Revive Therapeutics Ltd. (RVV.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.61 Million CAD | 11.11% |
| 2022 | -6.32 Million CAD | 64.56% |
| 2021 | -17.83 Million CAD | 11.71% |
| 2020 | -20.19 Million CAD | -373.44% |
| 2019 | -4.26 Million CAD | -211.11% |
| 2018 | -1.37 Million CAD | 18.5% |
| 2017 | -1.68 Million CAD | -4.12% |
| 2016 | -1.61 Million CAD | 40.98% |
| 2015 | -2.73 Million CAD | -34.8% |
| 2014 | -2.03 Million CAD | -61.57% |
| 2013 | -1.25 Million CAD | -550.02% |
| 2012 | -193.39 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | -1.87 Million CAD | -142.91% |
| 2023 Q4 | -2.58 Million CAD | -38.11% |
| 2023 Q1 | -390.62 Thousand CAD | 67.24% |
| 2023 Q2 | -770.62 Thousand CAD | -97.28% |
| 2022 Q2 | -1.53 Million CAD | 8.11% |
| 2022 Q1 | -1.67 Million CAD | 40.9% |
| 2022 FY | -6.32 Million CAD | 64.56% |
| 2022 Q4 | -1.19 Million CAD | 38.66% |
| 2022 Q3 | -1.94 Million CAD | -26.51% |
| 2021 FY | -17.83 Million CAD | 11.71% |
| 2021 Q2 | -4.11 Million CAD | 15.52% |
| 2021 Q3 | -6.03 Million CAD | -46.76% |
| 2021 Q4 | -2.82 Million CAD | 53.14% |
| 2021 Q1 | -4.87 Million CAD | 44.98% |
| 2020 Q2 | -2.47 Million CAD | 38.44% |
| 2020 Q3 | -4.26 Million CAD | -72.36% |
| 2020 Q4 | -8.85 Million CAD | -107.37% |
| 2020 FY | -20.19 Million CAD | -373.44% |
| 2020 Q1 | -4.02 Million CAD | -31.97% |
| 2019 Q3 | -1.66 Million CAD | -345.27% |
| 2019 Q2 | -372.87 Thousand CAD | -21.02% |
| 2019 Q4 | -3.04 Million CAD | -83.59% |
| 2019 Q1 | -308.1 Thousand CAD | 33.65% |
| 2019 FY | -4.26 Million CAD | -211.11% |
| 2018 FY | -1.37 Million CAD | 18.5% |
| 2018 Q4 | -464.35 Thousand CAD | -85.04% |
| 2018 Q3 | -250.94 Thousand CAD | 22.21% |
| 2018 Q2 | -322.58 Thousand CAD | -5.42% |
| 2018 Q1 | -305.99 Thousand CAD | 40.43% |
| 2017 Q3 | -400.96 Thousand CAD | 7.66% |
| 2017 Q4 | -513.67 Thousand CAD | -28.11% |
| 2017 FY | -1.68 Million CAD | -4.12% |
| 2017 Q2 | -434.21 Thousand CAD | 1.76% |
| 2017 Q1 | -441.99 Thousand CAD | 17.3% |
| 2016 Q1 | -357.7 Thousand CAD | 30.75% |
| 2016 FY | -1.61 Million CAD | 40.98% |
| 2016 Q4 | -534.47 Thousand CAD | -18.06% |
| 2016 Q3 | -452.7 Thousand CAD | -67.04% |
| 2016 Q2 | -271.01 Thousand CAD | 24.24% |
| 2015 Q3 | -496.67 Thousand CAD | 38.83% |
| 2015 Q2 | -811.91 Thousand CAD | 11.05% |
| 2015 FY | -2.73 Million CAD | -34.8% |
| 2015 Q1 | -912.79 Thousand CAD | -53.11% |
| 2015 Q4 | -516.54 Thousand CAD | -4.0% |
| 2014 Q4 | -596.16 Thousand CAD | -3.57% |
| 2014 Q3 | -575.64 Thousand CAD | -24.95% |
| 2014 Q2 | -460.7 Thousand CAD | -15.58% |
| 2014 Q1 | -398.58 Thousand CAD | 65.59% |
| 2014 FY | -2.03 Million CAD | -61.57% |
| 2013 Q2 | -560.3 Thousand CAD | -573.99% |
| 2013 Q3 | -278.87 Thousand CAD | 50.23% |
| 2013 Q4 | -1.15 Million CAD | -315.39% |
| 2013 Q1 | -83.13 Thousand CAD | -2510.11% |
| 2013 FY | -1.25 Million CAD | -550.02% |
| 2012 Q2 | -62.13 CAD | -742.77% |
| 2012 Q1 | -7.37 CAD | 0.0% |
| 2012 FY | -193.39 Thousand CAD | 0.0% |
| 2012 Q3 | -29.16 Thousand CAD | -46841.04% |
| 2012 Q4 | -3185.00 CAD | 89.08% |
| 2011 Q4 | - CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | 10.634% |
| Ayurcann Holdings Corp. | -3.96 Million CAD | -41.608% |
| Blueberries Medical Corp. | -1.63 Million CAD | -243.568% |
| The BC Bud Corporation | -1.22 Million CAD | -359.017% |
| BioNxt Solutions Inc. | -7.72 Million CAD | 27.248% |
| CordovaCann Corp. | -6.88 Million CAD | 18.389% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | -35.984% |
| Captor Capital Corp. | -11.38 Million CAD | 50.631% |
| City View Green Holdings Inc. | -2.44 Million CAD | -129.463% |
| 1CM Inc. | -913.85 Thousand CAD | -514.825% |
| Global Hemp Group Inc. | -2.58 Million CAD | -117.731% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -18.971% |
| IM Cannabis Corp. | -9.49 Million CAD | 40.844% |
| Lobe Sciences Ltd. | -4.7 Million CAD | -19.359% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -414.749% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 26.745% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 2615.793% |
| Ovation Science Inc. | -813.14 Thousand CAD | -590.971% |
| Pharmadrug Inc. | -13.2 Million CAD | 57.439% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | 7.666% |
| RAMM Pharma Corp. | -7.72 Million CAD | 27.229% |
| RIV Capital Inc. | -106.76 Million CAD | 94.737% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 95.955% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 70.988% |
| 1933 Industries Inc. | -13.36 Million CAD | 57.957% |
| Red Light Holland Corp. | -7.62 Million CAD | 26.335% |
| Top Strike Resources Corp. | -1.72 Million CAD | -226.658% |
| Xebra Brands Ltd. | -1.95 Million CAD | -187.048% |
| Adastra Holdings Ltd. | -3.54 Million CAD | -58.51% |